Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The pan-cancer landscape of crosstalk between epithelial-mesenchymal transition and immune evasion relevant to prognosis and immunotherapy response

22 Jun 2021

Abstract excerpt

An emerging body of evidence has recently recognized the coexistence of epithelial-mesenchymal transition (EMT) and immune response. However, a systems-level view and survey of the interplay between EMT and immune escape program, and their impact on tumor behavior and clinical outcome across various types of cancer is lacking. Here, we performed comprehensive multi-omics analyses to characterize the landscape of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Cancer Immunotherapy and Biomarkers
Share to Ferroptosis and cancer prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34158591
DOI: 10.1038/s41698-021-00200-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The pan-cancer landscape of crosstalk between epithelial-mesenchymal transition and immune evasion relevant to prognosis and immunotherapy responsePMID 34158591Read ↗

Pan‐cancer survey of epithelial–mesenchymal transition markers across the Cancer Genome AtlasSemantic proximity Read ↗

EMTome: a resource for pan-cancer analysis of epithelial-mesenchymal transition genes and signaturesSemantic proximity Read ↗

Epithelial-to-mesenchymal transition in cancer progression: unraveling the immunosuppressive module driving therapy resistance.Semantic proximity Read ↗

Pan-sarcoma characterization of lncRNAs in the crosstalk of EMT and tumor immunity identifies distinct clinical outcomes and potential implications for immunotherapySemantic proximity Read ↗

Immunological Consequences of Epithelial–Mesenchymal Transition in Tumor ProgressionSemantic proximity Read ↗

A Pan-cancer Landscape of Interactions between Solid Tumors and Infiltrating Immune Cell PopulationsSemantic proximity Read ↗

Pan-cancer tumor classification by a holistic tumor microenvironment atlasSemantic proximity Read ↗

Pan-cancer landscape of T-cell exhaustion heterogeneity within the tumor microenvironment revealed a progressive roadmap of hierarchical dysfunction associated with prognosis and therapeutic efficacySemantic proximity Read ↗

A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition.Semantic proximity Read ↗

Modeling the effects of EMT-immune dynamics on epithelial cancer progressionSemantic proximity Read ↗

Interplay between tumor microenvironment and partial EMT as the driver of tumor progressionSemantic proximity Read ↗

Decoupling epithelial-mesenchymal transitions from stromal profiles by integrative expression analysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.